Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual investors should know.

Viking's dual-pathway GLP-1/GIP approach with both injectable and oral delivery options could differentiate it in the crowded obesity drug market. The company's Phase 2 oral VK2735 readout, expected ...

Robertet has invested in Aethera Biotech to boost its expertise in biotech and grow its health and beauty division. The ...

HOLLY SPRINGS, N.C. (WTVD) -- Governor Josh Stein spoke at the NCBioTech Summit in Charlotte, touting recent investment in the life sciences industry across the state. It comes less than one month ...

This year’s National Defense Authorization Act (NDAA), signed into law on December 18, 2025, introduces a series of US defense policy updates, ranging from reform of the defense acquisition system and ...

In this article, we will look at the 9 Most Profitable Biotech Stocks to Buy. On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space. She ...

Investment and networking platform AngelMD’s new report shows healthcare technology investment surged ahead in 2017, with California leading the charge and the biotechnology group more than doubling ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ — Bringing together public institutions, companies and investors to deepen the dialogue ...

Mon, August 4, 2025 at 11:15 AM UTC Viking Therapeutics (NASDAQ: VKTX) represents exactly this type of overlooked opportunity, trading at a valuation of just $3.7 billion as of Aug. 1, despite owning ...